3 Papers
1 Citations
Sean Burns is an academic researcher from Wrightington, Wigan and Leigh NHS Foundation Trust. The author has contributed to research in topics: Placebo & Endometrial cancer. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial.
Sarah Kitson,Zoe Maskell,Vanitha N Sivalingam,Jennifer L. Allen,S Ali,S Ali,Sean Burns,Kyle Gilmour,Rahamatulla Latheef,Richard J Slade,Philip W. Pemberton,Joseph Shaw,W David J Ryder,Henry C Kitchener,Emma J Crosbie,Emma J Crosbie +15 more
TL;DR: Short-term treatment with standard diabetic doses of metformin does not reduce tumor proliferation in women with endometrioid endometrial cancer awaiting hysterectomy and casts doubt on its potential application in the primary and adjuvant treatment settings.
Pre-Surgical Metformin in Uterine Malignancy (Premium): A Multi-Centre, Randomised Double-Blind, Placebo-Controlled Phase 3 Trial
Sarah Kitson,Zoe Maskell,Vanitha N Sivalingam,Jennifer L. Allen,Saad Ali,Saad Ali,Sean Burns,Kyle Gilmour,Rahamatulla Latheef,Richard J Slade,Phil Pemberton,Joseph Shaw,W David J Ryder,Henry C Kitchener,Henry C Kitchener,Emma J Crosbie +15 more
TL;DR: This paper showed that short-term treatment with standard diabetic doses of metformin does not reduce tumour proliferation in women with endometrial cancer awaiting hysterectomy and cast doubt on its potential application in the primary and adjuvant treatment settings.
2
Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial.
Kinta Beaver,Susan Williamson,Chris J Sutton,William Hollingworth,Anne Gardner,Barbara Allton,Mohamed Abdel-Aty,Karen Blackwood,Sean Burns,Debbie Curwen,Rauf Ghani,Patrick J. Keating,Sandra Murray,Anne Tomlinson,Beverley Walker,Mark Willett,Nicholas J Wood,Pierre L. Martin-Hirsch +17 more
TL;DR: To evaluate the effectiveness of nurse‐led telephone follow‐up (TFU) for patients with stage–I endometrial cancer, a large number of patients were referred for follow-up treatment with a single nurse.